Hyper-IgM syndrome type 4

From WikiMD's Food, Medicine & Wellness Encyclopedia

Hyper-IgM syndrome type 4 is a rare immunodeficiency disorder characterized by a decreased ability to fight infections. This condition is one of several types of hyper-IgM syndrome, which are all distinguished by low levels of certain types of antibodies in the blood.

Symptoms[edit | edit source]

People with Hyper-IgM syndrome type 4 have a reduced ability to produce specific types of antibodies, leading to a higher susceptibility to infections. These infections can be recurrent and can affect various parts of the body, including the respiratory system, gastrointestinal tract, and skin.

Causes[edit | edit source]

Hyper-IgM syndrome type 4 is caused by mutations in the activation-induced cytidine deaminase (AID) gene. This gene is involved in the process of class switch recombination, which is essential for the production of different types of antibodies.

Diagnosis[edit | edit source]

Diagnosis of Hyper-IgM syndrome type 4 is based on the presence of characteristic symptoms, a detailed patient history, a thorough clinical evaluation, and specialized tests such as genetic testing to identify mutations in the AID gene.

Treatment[edit | edit source]

Treatment is focused on managing the symptoms and preventing infections. This may include antibiotics, immunoglobulin therapy, and in severe cases, hematopoietic stem cell transplantation.

See also[edit | edit source]

Hyper-IgM syndrome type 4 Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Admin, Prab R. Tumpati, MD